A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1
Clinical trial NCT01266902 · COMPLETED
Trial details
- NCT number
- NCT01266902
- Sponsor
- Janssen R&D Ireland
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2020-02-01
- Enrollment
- 482
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.